BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$291.84 USD
+2.39 (0.83%)
Updated May 22, 2024 04:00 PM ET
After-Market: $291.62 -0.22 (-0.08%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Brokerage Reports
Bio-Rad Laboratories, Inc. [BIO]
Reports for Purchase
Showing records 101 - 120 ( 140 total )
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department